Literature DB >> 3141929

B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene.

S Y Tsang1, M Nakanishi, B M Peterlin.   

Abstract

We investigated the cis-acting sequences that function in the B-cell-specific and interferon-gamma-inducible expression of the HLA-DR alpha gene, a human class II major histocompatibility complex gene. The effects of 5' deletions on the activity of the DR alpha promoter and the influence of upstream DR alpha promoter elements on the activity of the herpes simplex virus thymidine kinase promoter were examined by a transient transfection assay in human B-, T-, and fibroblast cell lines. We show that the DR alpha gene is regulated by positive and negative cis-acting sequences between positions -1300 and +31 from the site of initiation of transcription. We also demonstrate that the DR alpha promoter sequences from positions -116 to -92 and from -136 to -80 are the minimal sequences required for conferring B-cell specificity and interferon-gamma inducibility upon the Herpes simplex virus thymidine kinase promoter, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141929      PMCID: PMC282506          DOI: 10.1073/pnas.85.22.8598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Chromosomal subunits in active genes have an altered conformation.

Authors:  H Weintraub; M Groudine
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

2.  Transcriptional enhancers in the HLA-DQ subregion.

Authors:  K E Sullivan; B M Peterlin
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

3.  Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family.

Authors:  B Servenius; L Rask; P A Peterson
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

4.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

Review 5.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  Chromatin structure of the HLA-DR alpha gene in different functional states of major histocompatibility complex class II gene expression.

Authors:  B M Peterlin; K J Hardy; A S Larsen
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

8.  Efficient infection of monkey cells with DNA of simian virus 40.

Authors:  L M Sompayrac; K J Danna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B-cells when introduced into an heterologous promoter.

Authors:  M Dreyfus; N Doyen; F Rougeon
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  A tissue-specific transcriptional enhancer is found in the body of the HLA-DR alpha gene.

Authors:  Y Wang; A S Larsen; B M Peterlin
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  56 in total

Review 1.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.

Authors:  J P Cogswell; P V Basta; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice.

Authors:  J W Chamberlain; H A Vasavada; S Ganguly; S M Weissman
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements.

Authors:  R N Pearse; R Feinman; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Conservation of the promoter region of DRA-like genes from nonhuman primates.

Authors:  L K Gaur; E R Heise; J P Ting
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  The MHC class II E beta promoter: a complex arrangement of positive and negative elements determines B cell and interferon-gamma (IFN-gamma) regulated expression.

Authors:  D Thanos; M Gregoriou; D Stravopodis; K Liapaki; T Makatounakis; J Papamatheakis
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

10.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.